Loading…
Aptus Pharma (BSE 544529)₹471.25+1.34%Pharmaceuticals
At the end of the Jun 2026 quarter, Aptus Pharma's shareholders were: promoters 72.93%, public 27.07%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 685 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters | 72.93% | 72.93% | 72.93% | 72.93% |
| FIIs | 10.06% | 0.00% | 0.00% | 0.00% |
| DIIs | 2.77% | 0.00% | 0.00% | 0.00% |
| Public | 14.24% | 27.07% | 27.07% | 27.07% |
| Promoter shares pledged | — | — | — | 0.00% |
| Number of shareholders | 212 | 301 | 336 | 685 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Tejash Maheshchandra Hathi | Promoter | 11.47% | +0.14 |
| Kapil Hasmukhbhai Chandarana | Promoter | 11.40% | +0.14 |
| Gaurang Rameshchandra Thakker | Promoter | 8.69% | +0.26 |
| Milly Chetan Lalseta | Promoter | 8.62% | +0.26 |
| Kripaliben Mayank Thakker | Promoter | 8.60% | +0.26 |
| Kunjal Piyushbhai Unadkat | Promoter | 8.60% | +0.26 |
| Riddhish Natwarlal Tanna | Promoter | 8.59% | +0.26 |
| Ghanshyam Vinubhai Pansuriya | Promoter | 5.28% | +0.21 |
| Chatrabhuj Vallabhbhai Butani | Promoter | 1.48% | −1.83 |
Promoters held 72.93% of Aptus Pharma at the end of the Jun 2026 quarter.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.00% (unchanged at 0.00% a quarter earlier) and domestic institutions (DIIs) held 0.00% (unchanged at 0.00% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Aptus Pharma had 685 shareholders at the end of the Jun 2026 quarter.